First Time Loading...

Taro Pharmaceutical Industries Ltd
NYSE:TARO

Watchlist Manager
Taro Pharmaceutical Industries Ltd Logo
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Watchlist
Price: 42.3 USD -0.26% Market Closed
Updated: May 13, 2024

Taro Pharmaceutical Industries Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Taro Pharmaceutical Industries Ltd
Income from Continuing Operations Peer Comparison

Comparables:
T
TEVA
I
INCR
MDWD
R
REKA
C
CSURE

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Income from Continuing Operations
$45.6m
CAGR 3-Years
N/A
CAGR 5-Years
-32%
CAGR 10-Years
-18%
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Income from Continuing Operations
-$617m
CAGR 3-Years
47%
CAGR 5-Years
23%
CAGR 10-Years
N/A
I
InterCure Ltd
TASE:INCR
Income from Continuing Operations
₪17.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-10%
Mediwound Ltd
NASDAQ:MDWD
Income from Continuing Operations
-$6.7m
CAGR 3-Years
10%
CAGR 5-Years
-3%
CAGR 10-Years
2%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Income from Continuing Operations
-₪8.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Cannassure Therapeutics Ltd
TASE:CSURE
Income from Continuing Operations
-₪5.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Taro Pharmaceutical Industries Ltd's Income from Continuing Operations?
Income from Continuing Operations
45.6m USD

Based on the financial report for Dec 31, 2023, Taro Pharmaceutical Industries Ltd's Income from Continuing Operations amounts to 45.6m USD.

What is Taro Pharmaceutical Industries Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-18%

Over the last year, the Income from Continuing Operations growth was -1%.